A new study co-written by a University of Illinois Urbana-Champaign expert in operations management finds that drugs approved under the U.S. Food and Drug Administration’s “Breakthrough Therapy Designation”—a program designed to expedite…
Continue Reading
News Source: medicalxpress.com
Leave a Reply